Publication date: 
10 January 2018
Last updated: 
Publication type: 
Intended audience: 
Health professionals

All companies are required to advise the Australian Technical Advisory Group on Immunisation (ATAGI) Secretariat of their intention to use parallel processing arrangements for vaccine submissions to the Pharmaceutical Benefits Advisory Committee (PBAC).

This should be communicated at the same time that ATAGI pre-submission advice is requested.

These files may not be suitable for users of assistive technology. Request an accessible format.